Latest news with #JournalCitationReports


Cision Canada
18-06-2025
- Science
- Cision Canada
Clarivate Unveils the 2025 Journal Citation Reports
LONDON, June 18, 2025 /CNW/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the 2025 update to the Journal Citation Reports (JCR). This is the 50 th anniversary of the industry-leading annual reports, which provide a comprehensive overview of the world's leading and trusted academic journals, offering academic institutions, researchers, and publishers the ability to gauge journals' trustworthiness and impact. Only journals that have met the rigorous quality standards for inclusion in the Web of Science Core Collection are featured within the Journal Citation Reports, which ensures users can confidently rely on the information and descriptive data provided. The annual reports provide a rich array of publisher–neutral data, metrics, and analysis to enhance user understanding of journal performance, including the widely recognized Journal Impact Factor (JIF) and the Journal Citation Indicator. Key highlights for the 2025 release: The JCR includes data from a total of 22,249 journals across 254 categories Over 6,200 of these were published via gold open access Scholarly journals from 111 countries are recognized and receive a JIF, including 14,591 in the sciences and 7,559 in the social sciences, as well as 3,368 journals in the arts and humanities 618 journals receive a JIF for the first time This year's release excludes citations to and from retracted content when calculating the JIF numerator, ensuring that citations from retracted articles do not contribute to the numerical value of the JIF. However, retracted articles will still be included in the article count (JIF denominator), maintaining transparency and accountability. This policy affects 1% of journals. Dr. Nandita Quaderi, Senior Vice President & Editor-in-Chief, Web of Science, Clarivate, said: "We are proud to remain true to our heritage while adapting to changes in the scholarly landscape. As we celebrate the 50th anniversary of the JCR, we are embracing our founder Eugene Garfield's vision and looking to the future, reinforcing our dedication to maintaining the integrity of the scientific record and continuing our journey towards a more equitable, transparent and trustworthy scholarly ecosystem." Emmanuel Thiveaud, Senior Vice President, Research and Analytics, Academia & Government at Clarivate said: "We are excited to present the 2025 edition of the Journal Citation Reports, which continues to serve as a vital tool for the global research community. These valuable data and insights empower researchers and institutions to make informed decisions, fostering the advancement of knowledge and innovation." To explore all available data, metrics and analysis visit the Journal Citation Reports. For more detailed information on this year's changes, please see our blog.


Cision Canada
02-06-2025
- Business
- Cision Canada
Clarivate and CAPES Expand Landmark Partnership to Power Research and Innovation Across Brazil
New five-year agreement delivers critical academic and life sciences insights into more than 400 institutions, broadening access and driving national research excellence LONDON, June 2, 2025 /CNW/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the renewal of its multi-year partnership with CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), significantly expanding access to trusted Academia & Government and Life Sciences & Healthcare data across over 400 Brazilian institutions. As compared to the previous contract, the agreement increases institutional coverage by 57%, extending the reach of high-quality research tools to universities and research centers across Brazil — from major metropolitan areas to the country's most remote regions. As a key agency under Brazil's Ministry of Education, CAPES plays a vital role in advancing postgraduate education, supporting high-level training, and fostering international scientific collaboration. A long-standing partner to CAPES, Clarivate began its collaboration with the agency in 2001, when the Web of Science became one of the first databases integrated into the CAPES Portal. This new agreement builds on that legacy, delivering enhanced access to solutions including Web of Science, Journal Citation Reports, Cortellis Drug Discovery Intelligence and Derwent Innovation Index. By bringing together world-class data and insights from academic research and the life sciences and healthcare sectors, the agreement empowers researchers and practitioners at all levels — including scholars, policy advisors, biomedical scientists and healthcare professionals — to conduct innovative research, develop new treatments, improve patient care, and inform policy decisions. It provides broad access to critical information, advancing evidence-based discovery, education and decision-making across disciplines. Matti Shem Tov, Chief Executive Officer, Clarivate, said:"This expanded partnership with CAPES is a powerful example of how strategic collaboration can accelerate research and innovation on a national scale. Brazil has made remarkable progress in advancing scientific excellence and global collaboration. We're proud to support this momentum by providing trusted data, insights, and technology to researchers across the country — from early discovery through impact assessment. Our shared commitment to expanding access and fostering innovation will continue to shape the future of research in Brazil and beyond." Denise Pires de Carvalho, President, CAPES, said: "Brazil is experiencing a moment of growing scientific output beyond its major urban centers, with resources now being distributed in a more equitable and democratic way to boost productivity across all regions. This collaboration with Clarivate enables us to better understand the scientific production profile of Brazilian institutions and supports more informed investment decisions to reduce regional disparities, which remains a significant national challenge. Many researchers in the North, Northeast and Center-West have limited access to the resources needed to give visibility to their work and expanding that access can make a meaningful difference." The renewed partnership reflects a shared commitment to democratizing access to critical scientific information and enabling data-driven research excellence. Through Web of Science, Journal Citation Reports, and Derwent Innovation Index, academic institutions and government agencies gain deeper visibility into global research trends, publication impact, and innovation pathways — supporting policy development, institutional benchmarking, and scholarly advancement. Complementing these capabilities, expanded access to Cortellis Drug Discovery Intelligence equips Brazil's life sciences community — including postgraduate students, faculty, and biomedical researchers — with comprehensive insights across biology, pharmacology, and chemistry. From disease understanding and drug interactions to clinical studies and intellectual property, users can more efficiently navigate the full R&D lifecycle and accelerate decision-making in high-impact research areas. By significantly expanding access to trusted research and innovation tools, this agreement supports CAPES' mission to reduce regional disparities and foster inclusive academic excellence. Institutions from across Brazil — from leading urban universities to those in underserved and remote regions — can now leverage high-quality data to strengthen postgraduate programs, accelerate innovation, and elevate the global visibility of Brazilian research. Clarivate values its collaboration with CAPES on this initiative to help shape a more connected, informed and future-ready research ecosystem across Brazil, and stands as a resource for academic consortia worldwide seeking to expand access to trusted research, data and insights. To learn more about this partnership and the solutions now available to CAPES institutions, visit here. Notes to editors According to the most recent Institute for Scientific Information G20 research and innovation scorecard: Around 40% of Brazilian research output is internationally collaborative, with many strong bilateral partnerships with the United States. It also participates in larger collaborations involving the U.S., the U.K., Spain, Germany, and France. Compared with other internationally collaborative output, these partnerships are producing papers with above average impact. Its research output shows a strong focus on Sustainable Development Goals (SDGs) Zero Hunger (SDG 2) and Life on Land (SDG 15), with impact for both around 0.7 to 0.8 times the world average. More broadly, Brazilian research output has a strong focus on the Life Sciences, while its output in Medicine has impact around 1.1 times the world average. Around 40% of output is published in open access (OA) journals, with their Humanities and Languages output 2.4 times more likely to be published in an OA journal than the G20 average. About Clarivate Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit About Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) is a consortium dedicated to expanding and strengthening postgraduate studies in Brazil. It ensures the quality of academic programs while fostering the development of highly qualified professionals in research, teaching, and other strategic scientific fields. Media contacts: Clarivate Catherine Daniel Director, External Communications – Life Sciences & Healthcare [email protected] CAPES João Mendes Communications [email protected] SOURCE Clarivate Plc


South China Morning Post
24-04-2025
- Science
- South China Morning Post
Breaking ranks: China's new journal publishing benchmarks to boost scientific soft power
Recent changes to a ranking system that covers thousands of scientific journals in China suggest an attempt by Beijing to reshape the global scientific publishing landscape by showcasing the country's growing scientific soft power, according to experts. Advertisement The National Science Library under the Chinese Academy of Sciences (CAS) released an updated Journal Ranking Table in March. The new ranking system covers around 22,000 journals across 21 major disciplines, sorting them into four tiers in each discipline, according to self-defined evaluation criteria. This ranking is now a critical component of China's research evaluation system. Many universities and research institutions use it to assess researcher output , evaluate promotions, and even determine whether doctoral students can graduate. After a previous update to the ranking table in 2023, the latest publication was noteworthy, particularly after some established international top-tier journals were downgraded to the second tier. In contrast, domestic Chinese journals displayed impressive improvements, with some advancing to higher rankings. Advertisement In one instance, a well-regarded materials science journal with an impact factor of 9.6, according to the widely recognised Journal Citation Reports by Clarivate, was downgraded to the second tier. In another case, the Chinese Science Bulletin – a Chinese-language journal jointly sponsored by the CAS and the National Natural Science Foundation of China – with a modest impact factor of 1.1, was rated as a top-tier journal.